Search

everythinglearnresearchcommunity

for

Search:↓

The Trust tonic is more effective than minoxidil for treating hair loss.

The combination of minoxidil and finasteride is more effective for hair growth than minoxidil alone.

Topical minoxidil 1% and 2% are twice as effective as placebo for female pattern hair loss.

The document concludes that low-dose oral minoxidil successfully regrew hair in a patient with permanent hair loss after chemotherapy and stem cell transplant.

Taking finasteride every other month can still help with hair loss but may be less effective over time compared to taking it daily.

UV exposure reduces Lgr6+ stem cells in mouse skin and they don't significantly contribute to skin cancer development.

Minoxidil is the only drug proven to improve female hair loss, and dextroamphetamine sulfate may be a new treatment for certain types of hair loss.

Chemotherapy often causes temporary hair loss, which is distressing and needs better treatment and support.

The evidence for using Low-Level Laser Therapy for hair loss is limited and more thorough research is needed.

UV rays can cause a type of hair loss known as telogen alopecia.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

Fractional lasers could help hair regrowth in androgenic alopecia, but more research is needed to confirm their effectiveness and safety.

The conclusion is that effectively treating hair disorders is difficult due to the complex factors affecting hair growth and more research is needed to improve treatments.

No FDA-approved treatments for chemotherapy-induced hair loss existed in 2006; more research was needed.

Chemotherapy causes hair loss by damaging hair follicles and stem cells, with more research needed for prevention and treatment.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Microneedling is promising for treating various skin issues but needs more research to confirm its effectiveness and safety.

Some drugs can cause hair loss, change hair color and shape, or increase hair growth, and treatment may involve stopping the drug or using specific hair growth treatments.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

Hydralazine and minoxidil are blood pressure medications that relax blood vessels, with potential side effects like rapid heartbeat and fluid retention, and are used for severe or pregnancy-related hypertension.

Some drugs can cause hair loss, excessive growth, or color changes, often reversible but sometimes permanent.

Hair loss from mood stabilizers is common but can be managed without stopping the medication.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

The document explains hair biology, the causes of hair loss, and reviews various hair loss treatments.

Flutamide improves female hair loss when other treatments fail, but may cause liver toxicity.

Finasteride may help some women with hair loss, but better options exist.

Minoxidil and finasteride are the best for non-scarring hair loss; more research is needed for scarring hair loss treatments.

The document concludes that PK/PD modeling is important for determining the safe and effective dosages of drugs.